UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


 

 

 

 

 

 

 

 

 

 

FORM 10-Q

 

 

 

 

 

 

 


 

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED
September 30, 2010; OR

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM
__________TO __________.

Commission File Number: 000-20728

 

 


 

 

 

 

RIMAGE CORPORATION

 

 

(Exact name of registrant as specified in its charter)

 


 

 

 

 

 

 

 

Minnesota

 

 

41-1577970

 

(State or other jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

 


 

 

 

 

7725 Washington Avenue South, Edina, MN 55439

 

 

(Address of principal executive offices)

 


 

 

 

 

952-944-8144

 

(Registrant’s telephone number, including area code)


 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act):

Large Accelerated Filer   Accelerated Filer   Non-Accelerated Filer   Smaller Reporting Company  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes  No 

Common Stock outstanding at October 31, 2010 -- 9,559,733 shares of $.01 par value Common Stock.

1

RIMAGE CORPORATION
FORM 10-Q
TABLE OF CONTENTS
FOR THE QUARTER ENDED SEPTEMBER 30, 2010

 

 

 

 

 

 

 

 

Description

 

 

Page

 

 

 

 

 

 

PART 1

 

FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

Item 1.

 

Financial Statements (unaudited)

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2010 and December 31, 2009

 

3

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2010 and 2009

 

4

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2010 and 2009

 

5

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

6-15

 

 

 

 

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

16-23

 

 

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risk

 

23

 

 

 

 

 

 

Item 4.

 

Controls and Procedures

 

23

 

 

 

 

 

 

PART II

 

OTHER INFORMATION

 

24

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

 

 

 

 

 

 

 

 

Item 1A.

 

Risk Factors

 

 

 

 

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities

 

 

 

 

 

 

 

 

Item 4.

 

[Removed and Reserved]

 

 

 

 

 

 

 

 

Item 5.

 

Other Information

 

 

 

 

 

 

 

 

Item 6.

 

Exhibits

 

 

 

 

 

 

 

 

SIGNATURES

 

25

2



 

PART 1 – FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

RIMAGE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(unaudited - in thousands, except share data)

 

 

 

 

 

 

 

 

Assets

 

September 30,
2010

 

December 31,
2009

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

96,879

 

$

72,507

 

Marketable securities

 

 

9,682

 

 

28,581

 

Receivables, net of allowance for doubtful accounts and sales returns of $328 and $327, respectively

 

 

14,412

 

 

13,732

 

Inventories

 

 

5,600

 

 

4,123

 

Prepaid expenses and other current assets

 

 

942

 

 

1,271

 

Deferred income taxes - current

 

 

566

 

 

546

 

Total current assets

 

 

128,081

 

 

120,760

 

Marketable securities - non-current

 

 

6,716

 

 

9,037

 

Property and equipment, net

 

 

7,837

 

 

7,855

 

Deferred income taxes - non-current

 

 

2,438

 

 

2,630

 

Other assets - non-current

 

 

230

 

 

 

Total assets

 

$

145,302

 

$

140,282

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Trade accounts payable

 

$

5,889

 

$

6,898

 

Accrued compensation

 

 

3,500

 

 

3,834

 

Other accrued expenses

 

 

719

 

 

911

 

Income taxes payable

 

 

50

 

 

222

 

Deferred income and customer deposits

 

 

6,092

 

 

5,706

 

Other current liabilities

 

 

57

 

 

18

 

Total current liabilities

 

 

16,307

 

 

17,589

 

 

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

 

 

Deferred income and customer deposits - non-current

 

 

1,437

 

 

2,452

 

Income taxes payable - non-current

 

 

205

 

 

213

 

Other non-current liabilities

 

 

66

 

 

79

 

Total long-term liabilities

 

 

1,708

 

 

2,744

 

Total liabilities

 

 

18,015

 

 

20,333

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

Rimage stockholders’ equity:

 

 

 

 

 

 

 

Preferred stock, $.01 par value, authorized 250,000 shares, no shares issued and outstanding

 

 

 

 

 

Common stock, $.01 par value, authorized 29,750,000 shares, issued and outstanding 9,551,087 and 9,471,885 respectively

 

 

96

 

 

94

 

Additional paid-in capital

 

 

42,269

 

 

40,296

 

Retained earnings

 

 

83,857

 

 

78,782

 

Accumulated other comprehensive income

 

 

507

 

 

777

 

Total Rimage stockholders’ equity

 

 

126,729

 

 

119,949

 

Noncontrolling interest

 

 

558

 

 

 

Total stockholders’ equity

 

 

127,287

 

 

119,949

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

145,302

 

$

140,282

 

See accompanying notes to condensed consolidated financial statements.

3


RIMAGE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(unaudited - in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$

20,948

 

$

19,731

 

$

56,601

 

$

52,224

 

Service

 

 

2,419

 

 

2,634

 

 

7,439

 

 

8,317

 

Total revenues

 

 

23,367

 

 

22,365

 

 

64,040

 

 

60,541

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

 

9,912

 

 

9,401

 

 

27,525

 

 

26,142

 

Service

 

 

1,763

 

 

1,867

 

 

5,536

 

 

5,549

 

Total cost of revenues

 

 

11,675

 

 

11,268

 

 

33,061

 

 

31,691

 

Gross profit

 

 

11,692

 

 

11,097

 

 

30,979

 

 

28,850

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

1,796

 

 

1,514

 

 

4,654

 

 

4,990

 

Selling, general and administrative

 

 

6,412

 

 

5,009

 

 

18,709

 

 

15,499

 

Total operating expenses

 

 

8,208

 

 

6,523

 

 

23,363

 

 

20,489

 

Operating income

 

 

3,484

 

 

4,574

 

 

7,616

 

 

8,361

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest, net

 

 

110

 

 

309

 

 

406

 

 

1,323

 

Realized gain on sale of marketable securities

 

 

 

 

 

 

 

 

278

 

Gain on currency exchange

 

 

38

 

 

5

 

 

6

 

 

47

 

Other, net

 

 

 

 

(4

)

 

4

 

 

(5

)

Total other income, net

 

 

148

 

 

310

 

 

416

 

 

1,643

 

Income before income taxes

 

 

3,632

 

 

4,884

 

 

8,032

 

 

10,004

 

Income tax expense

 

 

1,335

 

 

1,775

 

 

2,987

 

 

3,737

 

Net income

 

 

2,297

 

 

3,109

 

 

5,045

 

 

6,267

 

Net loss attributable to the noncontrolling interest

 

 

30

 

 

 

 

30

 

 

 

Net income attributable to Rimage

 

$

2,327

 

$

3,109

 

$

5,075

 

$

6,267

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per basic share

 

$

0.24

 

$

0.33

 

$

0.53

 

$

0.67

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per diluted share

 

$

0.24

 

$

0.33

 

$

0.53

 

$

0.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

9,559

 

 

9,376

 

 

9,522

 

 

9,364

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

 

9,621

 

 

9,564

 

 

9,600

 

 

9,494

 

See accompanying notes to condensed consolidated financial statements.

4


RIMAGE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(unaudited - in thousands)

 

 

 

 

 

 

 

 

 

 

Nine months ended
September 30,

 

   

2010

 

2009

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income

 

$

5,045

 

$

6,267

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,445

 

 

897

 

Deferred income tax benefit

 

 

252

 

 

(305

)

Gain on sale of marketable securities

 

 

 

 

(278

)

Loss on disposal of property and equipment

 

 

5

 

 

2

 

Stock-based compensation

 

 

1,486

 

 

1,213

 

Excess tax benefits from stock-based compensation

 

 

(21

)

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Receivables

 

 

(868

)

 

(3,252

)

Inventories

 

 

(1,480

)

 

1,506

 

Prepaid income taxes/income taxes payable

 

 

(226

)

 

659

 

Prepaid expenses and other current assets

 

 

124

 

 

991

 

Trade accounts payable

 

 

1,454

 

 

790

 

Accrued compensation

 

 

(203

)

 

840

 

Other accrued expenses and other current liabilities

 

 

(321

)

 

(28

)

Deferred income and customer deposits

 

 

(646

)

 

2,598

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

 

6,046

 

 

11,900

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Purchases of marketable securities

 

 

 

 

(58,119

)

Maturities and sales of marketable securities

 

 

21,013

 

 

43,460

 

Purchases of property and equipment

 

 

(3,817

)

 

(208

)

 

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

 

17,196

 

 

(14,867

)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Contribution from noncontrolling interest

 

 

588

 

 

 

Principal payments on capital lease obligations

 

 

(14

)

 

(19

)

Excess tax benefits from stock-based compensation

 

 

21

 

 

 

Proceeds from stock option exercises

 

 

536

 

 

284

 

 

 

 

 

 

 

 

 

Net cash provided by financing activities

 

 

1,131

 

 

265

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(1

)

 

142

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

 

24,372

 

 

(2,560

)

 

 

 

 

 

 

 

 

Cash and cash equivalents, beginning of period

 

 

72,507

 

 

14,885

 

 

 

 

 

 

 

 

 

Cash and cash equivalents, end of period

 

$

96,879

 

$

12,325

 

 

 

 

 

 

 

 

 

Supplemental disclosures of net cash paid during the period for:

 

 

 

 

 

 

 

Income taxes

 

$

3,014

 

$

2,980

 

See accompanying notes to condensed consolidated financial statements.

5


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

(1)

Basis of Presentation and Nature of Business

 

 

 

Rimage Corporation (“the Company” or “Rimage”) develops, manufactures and markets workflow-integrated digital publishing solutions that are used by businesses to produce CD/DVD/Blu-ray discs with customized content and durable disc labeling. Rimage distributes its publishing systems from its operations in the United States, Germany, Japan, and effective in the third quarter 2010, from its joint venture operation in China. The Company also distributes related consumables for use with its systems, consisting of media kits, ribbons, ink cartridges and Rimage-branded blank CD-R, DVD-R and Blu-ray media.

 

 

 

The accompanying condensed consolidated financial statements are unaudited and have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the financial statements have been condensed or omitted. However, in the opinion of management, the financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the financial position and results of operations and cash flows of the interim periods presented. Operating results for these interim periods are not necessarily indicative of results to be expected for the entire year, due to seasonal, operating and other factors. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K as of and for the year ended December 31, 2009.

 

 

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates on items such as allowance for doubtful accounts and sales returns, inventory provisions, asset impairment charges, deferred tax asset valuation allowances, accruals for uncertain tax positions and warranty accruals. These estimates and assumptions are based on management’s best judgment. Management evaluates estimates and assumptions on an ongoing basis using its technical knowledge, historical experience and other factors, including consideration of the impact of the current economic environment. Management believes its assumptions are reasonable in light of the current economic environment. Management adjusts such estimates and assumptions when facts and circumstances change. Illiquid credit markets, volatile equity, foreign currency and energy markets, and declines in business and consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.

 

 

(2)

Stock-Based Compensation

 

 

 

In May 2007, the Company’s shareholders approved the 2007 Stock Incentive Plan (the “2007 Plan”). The 2007 Plan provides for the grant of stock incentive awards in the form of incentive and non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock, performance units and other awards in stock and/or cash to certain key employees, non-employee directors and service providers. In May 2009, the Company’s shareholders approved amendments to the 2007 Plan, including an increase in the number of shares authorized for issuance by 500,000

6


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

shares to a total of 1,230,320 shares. At September 30, 2010, a total of 420,808 shares were available for future grant under the 2007 Plan, as amended. Effective with the approval of the 2007 Plan in May 2007, the Company may not issue any new awards or options under its Amended and Restated 1992 Stock Option Plan (the “1992 Plan”). The exercise price of stock options granted under the 2007 Plan is equal to the market value on the date of grant. Options issued to employees through March 31, 2006 under the 1992 Plan generally become exercisable over a two-year period and terminate ten years from the date of grant. Options issued to employees after March 31, 2006 under both the 1992 Plan and the 2007 Plan generally become exercisable over a four-year period. Options issued to employees through May 13, 2008 under the 1992 Plan and the 2007 Plan terminate ten years from the date of grant, while options issued effective May 14, 2008 under the 2007 Plan terminate seven years from the date of grant. Stock options granted to non-employee directors vest six months from the date of grant and terminate ten years from the date of grant. Restricted stock and restricted stock unit awards issued to employees and non-employee directors under the 2007 Plan are subject to the risk of forfeiture and transfer restrictions that lapse in varying time periods from the date of grant.

 

 

 

In addition to awards granted under the 2007 Plan and 1992 Plan, the Company granted a non-qualified option to purchase 200,000 shares of its common stock to a newly hired executive officer on April 1, 2009. The option was granted outside of any shareholder-approved plan as an inducement to accept employment with the Company. The option has an exercise price equal to the closing price of the Company’s common stock as reported by the Nasdaq Stock Market on the first day of employment of April 1, 2009, vests in four equal installments on each of the first four anniversaries of the date of grant and has a term of seven years. In other respects, the option was structured to mirror the terms of options granted under the 2007 Plan and is subject to a stock option plan between the Company and the executive officer.

 

 

 

Under the guidance of the Stock Compensation Topic of the Codification, stock-based compensation expense is determined based on the grant-date fair value and is recognized on a straight-line basis over the vesting period for each stock-based award granted on or after January 1, 2006, and for previously granted awards not yet vested as of January 1, 2006. The Company recognizes stock-based compensation net of an estimated forfeiture rate, resulting in the recognition of compensation cost for only those shares expected to vest. Compensation cost is recognized for all awards over the vesting period to the extent the employees or directors meet the requisite service requirements, whether or not the award is ultimately exercised. Conversely, when an employee or director does not meet the requisite service requirements and forfeits the award prior to vesting, any compensation expense previously recognized for the award is reversed. The Company recognized stock-based compensation costs of $484,000 and $1,486,000 for the three and nine months ended September 30, 2010, respectively, compared to $413,000 and $1,212,000 for the comparable periods in 2009.

 

 

 

The fair value of each option award is estimated at the date of grant using the Black-Scholes option pricing model. The following key assumptions were utilized in valuing option awards issued during the nine months ended September 30, 2010 and 2009:

7


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

 

 

 

 

 

Nine Months Ended September,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Expected life of options in years

 

4.75

 

4.75

 

 

 

 

 

 

 

Risk-free interest rate

 

1.6% - 2.65

%

1.6% - 2.2

%

 

 

 

 

 

 

Expected volatility

 

49.2% - 49.6

%

48.5% - 49.7

%

 

 

 

 

 

 

Expected dividend yield

 

0.0

%

0.0

%


 

 

 

The Company reviews these assumptions at the time of each new option award and adjusts them as necessary to ensure proper option valuation. The expected life represents the period that the stock option awards are expected to be outstanding. Effective April 2008, the Company’s Board of Directors approved a change in the contractual term of stock options granted to employees from ten to seven years. Given the reduction in the contractual term of its employee stock option awards, the Company determined it was unable to rely on its historical exercise data as a basis for estimating the expected life of stock options granted to employees subsequent to this change. As such, the Company used the “simplified” method for determining the expected life of stock options granted to employees in 2008, 2009 and 2010, as specified by Staff Accounting Bulletin (“SAB”) No. 107, “Valuation of Share-Based Payment Arrangements for Public Companies,” which bases the expected life calculation on the average of the vesting term and the contractual term of the awards. The risk-free interest rate is based on the yield of constant maturity U.S. treasury bonds with a remaining term equal to the expected life of the awards. The Company estimated the stock price volatility using historical weekly price observations over the expected life of the awards. The expected dividend yield is zero as the Company has not paid or declared any cash dividends on its common stock and does not currently have plans to pay dividends.

Other information pertaining to stock options is as follows:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

(in thousands, except per share data)

 

(in thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of options granted

 

 

67

 

 

50

 

 

284

 

 

400

 

Fair value of options granted

 

$

488

 

$

352

 

$

2,138

 

$

2,503

 

Per share weighted average fair value of options granted

 

$

7.23

 

$

7.03

 

$

7.52

 

$

6.25

 

Total fair value of stock options vested

 

$

84

 

$

 

$

1,053

 

$

949

 

Total intrinsic value of stock options exercised

 

$

 

$

 

$

528

 

$

151

 

Total intrinsic value of stock options outstanding

 

$

1,676

 

$

3,163

 

$

1,676

 

$

3,163

 

8


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

Cash received from the exercise of stock options was $536,000 and $284,000 for the nine months ended September 30, 2010 and 2009, respectively. The exercise of stock options, expirations of vested stock options and lapse of restrictions on restricted stock generated a net non-deductible income tax impact of $48,000 and $70,000 during the nine months ended September 30, 2010 and 2009, respectively. The income tax impact was recorded as a reduction to additional paid-in capital.

 

 

(3)

Accounting for Uncertainty in Income Taxes

 

 

 

Gross unrecognized tax benefits recorded under the guidance of the Income Taxes Topic of the Codification as of September 30, 2010 and December 31, 2009 totaled $350,000 and $364,000, respectively (excluding interest and penalties). Changes in gross unrecognized tax benefits during the nine months ended September 30, 2010 consisted primarily of a net increase of $16,000 for tax positions taken in the current year and a net decrease of $29,000 for tax positions taken in prior years. Included in the balance of unrecognized tax benefits at September 30, 2010 are potential benefits of $143,000 that if recognized, would affect the effective tax rate. The difference between this amount and the corresponding amount of gross unrecognized tax benefits relates primarily to deferred federal benefits of uncertain tax positions. The Company made no other material adjustments to its unrecognized tax benefits during the nine months ended September 30, 2010.

 

 

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense. Total accrued interest and penalties amounted to $42,000 and $36,000 on a gross basis at September 30, 2010 and December 31, 2009, respectively, and are excluded from the gross amounts of unrecognized tax benefits reflected above.

 

 

 

The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. As of September 30, 2010, the Company was no longer subject to income tax examinations for taxable years before 2007 and 2005 in the case of U.S. federal and German taxing authorities, respectively, and taxable years generally before 2005 in the case of state taxing authorities, consisting primarily of Minnesota, California and Maryland.

 

 

(4)

Marketable Securities

 

 

 

Marketable securities consist primarily of U.S. treasury bills, money market securities, municipal securities, corporate securities and U.S. government agency securities with long-term credit ratings of AAA and short-term credit ratings of A-1. Marketable securities are classified as either short-term or long-term in the consolidated balance sheet based on their effective maturity date. All marketable securities have original maturities ranging from three to 36 months. Marketable securities are classified as available-for-sale. Available-for-sale securities are recorded at fair value and any unrealized holding gains and losses, net of the related tax effect, are excluded from earnings and are reported as a separate component of accumulated other comprehensive income until realized. See Note 8, “Fair Value Measurements,” for a discussion of inputs used to measure the fair value of the Company’s available-for-sale securities. The Company’s marketable securities at September 30, 2010 did not include any auction-rate securities, “high-yield” sub-prime backed paper or other affected securities which are subject to significant market value declines or liquidity issues.

9


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

(5)

Inventories

 

 

 

Inventories consisted of the following (in thousands):


 

 

 

 

 

 

 

 

 

 

September 30,
2010

 

December 31,
2009

 

 

 

 

 

 

 

 

 

Finished goods and demonstration equipment

 

$

1,794

 

$

1,425

 

Purchased parts and subassemblies

 

 

3,806

 

 

2,698

 

 

 

$

5,600

 

$

4,123

 


 

 

(6)

Comprehensive Income

 

 

 

Comprehensive income consists of the Company’s net income, foreign currency translation adjustments, and unrealized holding gains and losses from available-for-sale securities. The components of and changes in other comprehensive income are as follows (in thousands):


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

2,327

 

$

3,109

 

$

5,075

 

$

6,267

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net changes in:

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

690

 

 

298

 

 

(144

)

 

128

 

Change in net unrealized gain on marketable securities, net of taxes

 

 

(26

)

 

(57

)

 

(126

)

 

(282

)

Total comprehensive income

 

$

2,991

 

$

3,350

 

$

4,805

 

$

6,113

 


 

 

(7)

Derivatives

 

 

 

The Company enters into forward foreign exchange contracts principally to hedge intercompany receivables denominated in Euros arising from sales to its subsidiary in Germany. The Company’s foreign exchange contracts do not qualify for hedge accounting under the Derivatives and Hedging Topic of the Codification. As a result, gains or losses related to mark-to-market adjustments on forward foreign exchange contracts are recognized as other income or expense in the income statement during the period in which the instruments are outstanding. The fair value of forward foreign exchange contracts represents the amount the Company would receive or pay to terminate the forward exchange contracts at the reporting date and is recorded in other current assets or other current liabilities depending on whether the net amount is a gain or a loss. The Company does not utilize financial instruments for trading or other speculative purposes.

 

 

 

As of September 30, 2010, the Company had eight outstanding foreign exchange contracts with a notional amount totaling approximately $684,000. These contracts mature during 2010 and bear exchange rates ranging from 1.2608 and 1.3635 U.S. Dollars per Euro. As of September 30, 2010, the fair value of foreign exchange contracts resulted in a net loss position of $39,000, which is recorded in other current liabilities.

10


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

As of December 31, 2009, the Company had three outstanding foreign exchange contracts with a notional amount totaling $550,000, all maturing during the first quarter of 2010 at exchange rates ranging from 1.4554 to 1.4913 U.S. Dollars per Euro. As of December 31, 2009, the fair value of foreign exchange contracts resulted in a net gain position of approximately $17,000, which is recorded in other current assets.

 

 

 

Realized and unrealized gains or losses on derivative instruments related to foreign currency exchange contracts and their location on the Company’s condensed consolidated statements of income are as follows (in thousands):


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended
September 30,

 

Derivative Instrument

 

Location

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Contracts

 

Gain (loss) on currency exchange

 

$

(115

)

$

217

 


 

 

 

The net gains or losses from foreign exchange contracts reflected above were largely offset by the underlying transaction net gains and losses arising from the foreign currency exposures to which these contracts relate.

 

 

 

The gross fair market value of derivative instruments related to foreign currency exchange contracts and their location on the Company’s condensed consolidated balance sheets are as follows as of September 30, 2010 (in thousands):


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset Derivatives

 

Liability Derivatives

 

Derivative Instrument

 

Location

 

September 30,
2010

 

Location

 

September 30,
2010

 

 

 

 

 

 

 

 

 

 

 

Foreign Exchange Contracts

 

Other current assets (1)

 

$

 

Other current liabilities(1)

 

$

(39

)


 

 

 

(1) As the Company’s foreign exchange agreement is subject to a master netting arrangement, the Company’s policy is to record the fair value of outstanding foreign exchange contracts as other current assets or other current liabilities, based on whether outstanding contracts are in a net gain or loss position, respectively. See Note 8, “Fair Value Measurements,” for additional information regarding the fair value measurements of derivative instruments related to foreign currency exchange contracts.

 

 

 

The Company enters into its foreign exchange contracts with a single counterparty, a financial institution. The Company manages its concentration of counterparty risk associated with foreign exchange contracts by periodically assessing relevant information such as the counterparty’s current financial statements, credit agency reports and/or credit references. To further mitigate credit risk, the Company’s Foreign Exchange Agreement with its counterparty includes a master netting arrangement, which allows netting of asset and liability positions of outstanding foreign exchange contracts if settlement were required.

 

 

(8)

Fair Value Measurements

 

 

 

A hierarchy for inputs used in measuring fair value is in place that distinguishes market data between observable independent market inputs and unobservable market assumptions by the reporting entity.

11


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

 

 

The hierarchy is intended to maximize the use of observable inputs and minimize the use of unobservable inputs by requiring that the most observable inputs be used when available. Three levels within the hierarchy may be used to measure fair value:

 

 

 

 

 

 

Level 1: Inputs are unadjusted quoted prices in active markets for identical assets and liabilities.

 

 

 

 

 

 

Level 2: Inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as interest rates and yield curves that are observable for the asset or liability, either directly or indirectly.

 

 

 

 

 

 

Level 3: Inputs are generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect an entity’s own estimates of assumptions that market participants would use in pricing the asset or liability.

 

 

 

 

 

The Company’s assets and liabilities measured at fair value on a recurring basis and the fair value hierarchy utilized to determine such fair values is as follows at September 30, 2010:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements Using

 

(in thousands)

 

Total Carrying
Value at
September 30, 2010

 

Quoted Prices in
Active Markets
(Level 1)

 

Significant Other
Observable
Inputs
(Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

$

16,398

 

$

 

$

16,398

 

$

 

Foreign currency forward exchange contracts

 

$

(39

)

$

 

$

(39

)

$

 


 

 

 

Available-for-sale securities in the preceding table are classified as either current or non-current marketable securities in the accompanying condensed consolidated balance sheets. Available-for-sale securities are carried at fair value based on significant observable inputs other than quoted market prices. Such inputs may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data. Foreign currency forward exchange contracts are also carried at fair value based on significant other observable market inputs, in this case, quoted foreign currency exchange rates. Such valuation represents the amount the Company would receive or pay to terminate the forward exchange contracts at the reporting date.

 

 

 

In September 2009, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2009-12, “Fair Value Measurements and Disclosures – Investments in Certain Entities That Calculate Net Asset Value per Share (or its Equivalent).” ASU 2009-12 allows companies to use net asset value as a practical expedient to estimate fair value of investments that are within the scope of this ASU that do not have readily determinable fair values. The Company adopted this guidance in the first quarter of 2010, and the adoption did not have a material impact on the Company’s consolidated financial statements.

12


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

(9)

Common Stock Repurchase Authorizations

 

 

 

On October 17, 2007, the Company’s Board of Directors authorized the repurchase of up to 500,000 shares of its common stock. In February 2008, the Company’s Board of Directors increased the share repurchase authorization by an additional 500,000 shares, bringing total shares authorized for repurchase to 1,000,000. Shares may be purchased at prevailing market prices in the open market or in private transactions, subject to market conditions, share price, trading volume and other factors. The repurchase program is funded from cash on hand and may be discontinued at any time. During the nine months ended September 30, 2010, the Company did not repurchase any shares of its common stock, and 422,917 shares remained available for repurchase under the authorizations as of September 30, 2010. Effective October 2010, the Company’s Board approved the continuation of common stock repurchases under the current authorization, and the Company repurchased less than $350,000 of its common stock during the fourth quarter prior to the filing of this Form 10-Q.

 

 

(10)

Recently Issued Accounting Standards

 

 

 

In October 2009, the FASB issued two new revenue recognition standards. The first new standard is ASU No. 2009-13, “Revenue Recognition (ASC Topic 605) – Multiple-Deliverable Revenue Arrangements, a consensus of the FASB Emerging Issues Task Force.” Under ASU No. 2009-13, when vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, a best estimate of the selling price is required to separate deliverables and allocate arrangement consideration using the relative selling price method. The second new standard is ASU No. 2009-14, “Software (Topic 985) – Certain Revenue Arrangements That Include Software Elements.” Under ASU 2009-14, tangible products that have software components that are essential to the functionality of the tangible product will no longer be within the scope of the software revenue recognition guidance, and software-enabled products will now be subject to the new guidance for multiple deliverable arrangements discussed above. The guidance under both standards is effective for revenue arrangements entered into or materially modified in fiscal years beginning after June 15, 2010. Early adoption is permitted, and the Company has elected to adopt the guidance under both standards on a prospective basis in the first quarter of 2010.

 

 

 

The adoption of ASU 2009-13 did not have a material impact on the Company’s consolidated financial statements, nor did it result in a significant change from prior periods in how the Company allocates arrangement consideration to various units of accounting and did not significantly change the pattern and timing of revenue recognition.

The Company earns revenues through the sale of tangible products, consisting primarily of equipment and consumables. As part of its product offering, the Company also sells optional services, consisting primarily of separately-priced maintenance contracts and installation services. When sold as a multiple-element arrangement, each of these deliverables qualifies as a separate unit of accounting.

Revenue for product sales is recognized upon shipment and transfer of risk of loss. Revenue associated with separately-priced maintenance agreements and installation services, however, is deferred until earned. Installation revenue is recognized upon successful completion of the service. In an arrangement including equipment, separately-priced maintenance and installation services, the amount deferred and recognized as revenue over the contract period for a separately-priced maintenance contract is the stated amount of the contract. The remaining consideration is allocated to the equipment and the installation service using the relative selling price method. The relative selling price is determined based on the Company’s stand-alone selling prices, or in the absence of stand-alone selling prices, estimated selling

13


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

 

prices for the equipment and installation service.

 

 

 

While the Company’s sales arrangements have not historically been within the scope of software revenue recognition guidance, the Company has elected to adopt the new guidance under ASU No. 2009-14 to facilitate application to potential future sales arrangements.

 

 

 

In January 2010, the FASB issued ASU 2010-06, “Fair Value Measurements and Disclosures – Improving Disclosures about Fair Value Measurements,” which requires new disclosures about recurring and nonrecurring fair-value measurements including significant transfers into and out of Level 1 and Level 2 of the fair value hierarchy. The ASU also requires additional information in the roll-forward of Level 3 assets and liabilities including the presentation of purchases, sales, issuances and settlements on a gross basis. Further clarification for existing disclosure requirements provides for the disaggregation of assets and liabilities presented, and the enhancement of disclosures around inputs and valuation techniques. This ASU impacts disclosures only. The Company adopted the disclosure provisions of this ASU in the first quarter of 2010, with the exception of the additional required information in the roll-forward of Level 3 assets and liabilities, which will be effective for the Company in the first quarter of 2011. No transfers of assets or liabilities into or out of Level 1 or 2 of the fair value hierarchy occurred or were required during the nine months ended September 30, 2010. The Company’s adoption of this guidance did not have a material impact on the Company’s consolidated financial statements and related disclosures.

 

 

(11)

Computation of Net Income Per Share of Common Stock

 

 

 

Basic net income per common share is determined by dividing net income by the basic weighted average number of shares of common stock outstanding. Diluted net income per common share includes the potentially dilutive effect of common shares issued in connection with outstanding stock options using the treasury stock method and the dilutive impact of restricted stock units. Stock options to acquire weighted average common shares of 1,188,000 and 1,121,000 for the three and nine months ended September 30, 2010, respectively, and weighted average common shares of 709,000 and 732,000 for the three and nine months ended September 30, 2009, respectively, have been excluded from the computation of diluted weighted average shares outstanding for each respective period as their effect is anti-dilutive. The following table identifies the components of net income per basic and diluted share (in thousands, except for per share data):


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares outstanding at end of period

 

 

9,551

 

 

9,380

 

 

9,551

 

 

9,380

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

9,559

 

 

9,376

 

 

9,522

 

 

9,364

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dilutive effect of stock options/restricted stock units

 

 

62

 

 

188

 

 

78

 

 

130

 

Total diluted weighted average shares outstanding

 

 

9,621

 

 

9,564

 

 

9,600

 

 

9,494

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Rimage

 

$

2,327

 

$

3,109

 

$

5,075

 

$

6,267

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per common share

 

$

0.24

 

$

0.33

 

$

0.53

 

$

0.67

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per common share

 

$

0.24

 

$

0.33

 

$

0.53

 

$

0.66

 

14


RIMAGE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

 

 

(12)

Contingencies

 

 

 

The Company is exposed to a number of asserted and unasserted claims encountered in the normal course of business. In the opinion of management, the resolution of these matters will not have a material adverse effect on the Company’s financial position or results of operations.

 

 

(13)

Consolidation of Joint Venture Entity and Noncontrolling Interest

 

 

 

In mid August 2010, the Company received approval of its registration of a majority-owned joint venture in China, Rimage Information Technology (Shanghai) Co., Ltd. (“RIT”), and was issued a business license which allowed initiation of operations. RIT will deploy a complete digital publishing solution for medical imaging in hospitals in China. The initial capitalization of RIT consisted of $1,200,000 in cash, of which Rimage invested $612,000 for a 51% interest, and Taiwan Electronic Data Processing (“TEDPC”), a Taiwanese software provider in the healthcare solutions market, invested $588,000 for the remaining 49% interest.

 

 

 

RIT will purchase digital publishing systems from Rimage and a license for medical disc system software source code from TEDPC, and integrate the software with Rimage’s digital publishing systems to allow deployment of a complete digital publishing solution in the Chinese medical imaging market. RIT has a commitment to pay TEDPC a minimum of $600,000 over the first three years of operations for the licensing of the software source code. Ownership of the source code and associated intellectual property will be transferred to RIT by TEDPC when the minimum payment has been fulfilled.

 

 

 

The key operating decisions of the entity are subject to simple majority approval of the Board of Directors of RIT, and Rimage has majority representation on the Board. Given Rimage’s control over the operations of RIT and its majority voting interest, the Company consolidates the financial statements of RIT with its consolidated financial statements, with the equity and earnings (loss) attributed to the noncontrolling interest identified separately in the accompanying condensed consolidated balance sheets and statements of income.

 

 

 

During the three and nine months ended September 30, 2010, RIT earned no revenues and incurred a net loss of approximately $60,000, of which approximately $30,000 was attributed to the noncontrolling interest. Consolidated stockholders’ equity as of September 30, 2010 included $558,000 attributable to the noncontrolling interest.

15



 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

The following table sets forth, for the periods indicated, selected items from the Company’s condensed consolidated statements of income.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage (%)
of Revenues
Three Months Ended
September 30,

 

Percentage (%)
Inc/(Dec)
Between
Periods

 

Percentage (%)
of Revenues
Nine Months Ended
September 30,

 

Percentage (%)
Inc/(Dec)
Between
Periods

 

 

 

2010

 

2009

 

2010 vs. 2009

 

2010

 

2009

 

2010 vs. 2009

 

Revenues

 

 

100.0

 

 

100.0

 

 

4.5

 

 

100.0

 

 

100.0

 

 

5.8

 

Cost of revenues

 

 

(50.0

)

 

(50.4

)

 

3.6

 

 

(51.6

)

 

(52.3

)

 

4.3

 

Gross profit

 

 

50.0

 

 

49.6

 

 

5.4

 

 

48.4

 

 

47.7

 

 

7.4

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

(7.7

)

 

(6.8

)

 

18.6

 

 

(7.3

)

 

(8.2

)

 

(6.7

)

Selling, general and administrative

 

 

(27.4

)

 

(22.3

)

 

28.0

 

 

(29.2

)

 

(25.7

)

 

20.7

 

Operating income

 

 

14.9

 

 

20.5

 

 

(23.8

)

 

11.9

 

 

13.8

 

 

(8.9

)

Other income, net

 

 

0.6

 

 

1.3

 

 

(52.3

)

 

0.7

 

 

2.7

 

 

(74.7

)

Income before income taxes

 

 

15.5

 

 

21.8

 

 

(25.6

)

 

12.6

 

 

16.5

 

 

(19.7

)

Income tax expense

 

 

(5.7

)

 

(7.9

)

 

(24.8

)

 

(4.7

)

 

(6.1

)

 

(20.1

)

Net income

 

 

9.8

 

 

13.9

 

 

(26.1

)

 

7.9

 

 

10.4

 

 

(19.5

)

Less noncontrolling interest

 

 

0.1

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Rimage

 

 

9.9

 

 

13.9

 

 

(25.2

)

 

7.9

 

 

10.4

 

 

(19.0

)


 

 

 

Overview

 

 

Rimage develops, manufactures and markets workflow-integrated digital publishing solutions that are used by businesses to produce CD/DVD/Blu-ray discs with customized content and durable disc labeling. Rimage distributes its publishing systems from its operations in the United States, Germany, Japan, and effective in the third quarter 2010, from its joint venture operation in China. The Company also distributes related consumables for use with its systems, consisting of ribbons, ink cartridges, Rimage-branded blank CD-R, DVD-R and Blu-ray media, or media kits, which combine these items for the customer’s convenience. These systems allow customers to benefit from cost savings by eliminating their manual labor efforts in markets and applications such as digital photography, medical imaging, business services, law enforcement and video workflows. As Rimage’s sales within North America and Europe have averaged 92% of total sales over the past three years, the strength of the economies in these regions plays an important role in determining the success of Rimage.

 

 

 

Rimage earns revenues through the sale of equipment, consumables and parts (included in Product revenues in the accompanying condensed consolidated statements of income), as well as maintenance contracts, repair and installation services (included in Service revenues in the condensed consolidated statements of income). Rimage’s recurring revenues (consumables, parts, maintenance contracts and service) comprised 56% and 61% of its consolidated revenues during the nine months ended September 30, 2010 and 2009, respectively. Exclusive of a small amount of capital lease obligations, Rimage has no long-term debt and does not require significant capital investment for its ongoing operations as all fabrication of tooling-intensive parts is outsourced to vendors.

 

 

 

As part of its plan to improve the efficiency of its sales channels, effective April 1, 2010, Rimage discontinued its distributor relationships with distributors in the United States, Germany, and the United Kingdom, and now sells products in these regions to end-user customers primarily through value-added resellers or other strategic partners, and also directly to select accounts through its own sales force.

16



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

In mid-August 2010, the Company received approval of its registration of a majority-owned joint venture in China, Rimage Information Technology (Shanghai) Co., Ltd. (“RIT”), and was issued a business license which allowed initiation of operations. The Chinese healthcare system’s transition from medical film to optical disc for distribution of patient imaging related information is expected to drive growth in the digital medical imaging market in China. As part of the Company’s strategy to participate in this growth opportunity, RIT will deploy a complete digital publishing solution for medical imaging in hospitals in China.

 

 

 

The initial capitalization of RIT consisted of $1,200,000 in cash, of which Rimage invested $612,000 for a 51% interest, and Taiwan Electronic Data Processing (“TEDPC”), a Taiwanese software provider in the healthcare solutions market, invested $588,000 for the remaining 49% interest. The Company consolidates the financial statements of RIT with its consolidated financial statements, with the equity and earnings (loss) attributed to the noncontrolling interest identified separately in the accompanying condensed consolidated balance sheets and statements of income. During the three and nine months ended September 30, 2010, RIT earned no revenues and incurred a net loss of approximately $60,000, of which approximately $30,000 was attributed to the noncontrolling interest. Consolidated stockholder’s equity as of September 30, 2010 included $558,000 attributable to the noncontrolling interest.

 

 

 

Results of Operations

 

 

 

Revenues. Total revenues increased 4% and 6% to $23.4 million and $64.0 million for the three and nine months ended September 30, 2010, respectively, from $22.4 million and $60.5 million for the respective prior-year periods. The increase in total revenues between periods reflects a $1.2 million and $4.4 million increase in product revenues for the three and nine months ended September 30, 2010, respectively, partially offset by a $0.2 million and $0.9 million decline in service-related revenues in each respective period. The increase in product revenues resulted from a $1.8 million and $5.0 million rise in sales of equipment for the three and nine months ended September 30, 2010, respectively, partially offset by a $0.6 million reduction in sales of consumable products in each respective period.

 

 

 

The overall increase in equipment sales in the current-year periods was primarily impacted by growth in retail equipment sales, driven by sales of $2.7 million in the third quarter and $5.6 million year to date under a multi-system sales agreement obtained in the second quarter with a retail customer. Also contributing to the revenue growth in the current-year periods were increased sales to federal government agencies, driven by sales of the Company’s new surveillance systems. These gains were partially offset by decreases in equipment sales in the Company’s European markets, impacted unfavorably by foreign currency fluctuations and reduced sales to medical OEM and channel partners. The decline in sales of consumable products in the current-year periods consisted of a reduced volume of ribbon and ink cartridge sales amounting to $0.8 million in the third quarter and $0.7 million in the year-to-date period, partially offset by increased sales of media and media kits of $0.2 million and $0.1 million in each respective period. Reduced utilization by end-user customers of the Company’s installed base of digital publishing systems in its U.S. and European markets impacted the reduction in ribbon and ink-cartridge sales. The decline in service-related revenues in both current-year periods was primarily impacted by the timing and amount of maintenance contract renewals resulting in the recognition of a reduced level of maintenance contract revenues.

Recurring revenues, consisting of consumables, parts, maintenance contracts and service, comprised 51% and 56% of total revenues for the three and nine months ended September 30, 2010,

17



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

respectively, compared to 57% and 61% in the same prior-year periods. Sales of Producer and Professional Series product line equipment comprised 45% and 40% of total revenues in the current-year’s third quarter and year-to-date periods, respectively, compared to 37% and 33% for the comparable periods in 2009. Remaining revenues in each period were generated by sales of Desktop product line equipment, representing 4% of revenues for the three and nine months ended September 30, 2010, compared to 6% in the respective prior-year periods.

 

 

 

International sales decreased 10% and 6% for the three and nine months ended September 30, 2010, respectively, compared to the same periods last year, and comprised 30% and 36% of total sales, compared to 35% and 40% in the same prior-year periods. The decline in international sales was driven by a 17% and 12% reduction in sales in the Company’s European market for the three and nine months ended September 30, 2010, respectively. Sales in the Company’s Asian markets were down 2% in the third quarter and rose 18% in the year-to-date period, compared to the prior year’s comparable periods. The current-period reductions in sales in the Company’s European markets were the result of a general decline in product sales and the impact of foreign currency fluctuations, which reduced European sales by approximately 10% and 4% for the third quarter and year-to-date periods, respectively. In the aggregate, currency fluctuations reduced reported consolidated revenues for the three and nine months ended September 30, 2010 by 2% and 1%, respectively.

 

 

 

Future revenues will be dependent upon many factors, including the effectiveness of changes that occurred effective April 1, 2010 to improve the efficiency of the Company’s sales channels, described in the “Overview” section above, the success of the Company’s deployment of a complete digital publishing solution for medical imaging in hospitals in China and the rate of adoption of other new solutions-based products introduced by the Company. Other factors that will influence future revenues include the performance of the Company’s channel partners, the timing of new product introductions, the timing of customer orders and related product deliveries, the rate of adoption of other new applications for the Company’s products in its targeted markets, the impact of changes in economic conditions and the impact of foreign currency exchange rate fluctuations.

 

 

 

Gross profit. Gross profit as a percentage of total revenues was 50.0% and 48.4% for the three and nine months ended September 30, 2010, compared to 49.6% and 47.7% for same periods in 2009. Gross profit as a percentage of total revenues for both current-year periods was favorably impacted by a higher concentration of Producer and Professional Series product line equipment sales, which generally carry higher gross margins than Desktop product line equipment or recurring revenues. Margins in both current-year periods were also favorably impacted by sales of the Company’s new surveillance systems, which contain a higher relative content of embedded software, and resulting higher margins. Additionally, margins benefitted from increased selling prices in the second and third quarters for product sales in the U.S. channel market, reflecting the impact of removing distributors from the Company’s U.S. sales distribution model effective April 1, 2010.

 

 

 

Partially offsetting the favorable impact of the above on gross profit as a percentage of revenue was the impact of foreign currency fluctuations which reduced reported revenues for the Company’s European operations to a greater degree than associated costs of revenue. Further, an increased volume and concentration of sales in the U.S. retail market segment, which generally carry lower selling prices, and a price reduction on sales of 8100N systems, the high-end of the Producer product line, resulted in an aggregate reduction in average selling prices for Producer and Professional Series equipment in the current-year periods, producing an unfavorable impact on equipment margins. Additionally, margins for the current year-to-date period were unfavorably impacted by a reduction in service-related revenues, impacted by the timing and amount of maintenance contract renewals, while

18



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

associated service support costs remained stable, primarily resulting from continued investments to strengthen the service support infrastructure of the Company’s international subsidiaries.

 

 

 

Future gross profit margins will continue to be affected by many factors, including the impact of recently implemented changes in the Company’s sales distribution model described above, product mix, the timing of new product introductions, the timing of customer orders and related product deliveries, changes in material costs, manufacturing volume, the growth rate of service related revenues relative to associated service support costs and foreign currency exchange rate fluctuations.

 

 

 

Operating expenses. Research and development expenses totaled $1.8 million and $4.7 million for the three and nine months ended September 30, 2010, respectively, representing 8% and 7% of revenues for each respective period. Expenses for the same prior-year periods totaled $1.5 million and $5.0 million, representing 7% and 8% of revenues, respectively. Expenses in the prior-year periods reflect costs incurred as part of a development arrangement with a third party supplier to develop the 5400N and 3400 Professional Series products launched by the Company in the first quarter of 2010. The Company incurred a lower level of expenses in the current year-to-date period as a result of the timing of activities associated with new product development projects scheduled for 2010. The expense growth in the current period’s third quarter was driven by increased compensation costs associated with late 2009 and 2010 personnel additions, coupled with increased spending on a new online publishing solution under development. Rimage anticipates expenditures in research and development in the fourth quarter 2010 will increase approximately 10% from the third quarter level.

 

 

 

Selling, general and administrative expenses for the three and nine months ended September 30, 2010 amounted to $6.4 million and $18.7 million, respectively, or 27% and 29% of revenues, compared to expenses in the same prior-year periods of $5.0 million and $15.5 million, respectively, or 22% and 26% of revenues. The rise in expenses in both current-year periods primarily reflects the impact of investments made to strengthen the Company’s core business and implement its growth strategy, including increased compensation-related costs from personnel additions, new hire recruiting costs, legal expenses associated with new business initiatives, travel expenses, promotional programs, increased equity compensation costs and expenses associated with the Company’s majority-owned joint venture established in China in the third quarter. Additionally, the Company incurred expenses in the current-year periods for the implementation of an enhanced sales order processing system to support the changes made effective April 1, 2010 in its sales distribution model, as well as the initiation of a project to further develop the reporting capabilities of its enterprise resource planning system. Expenses in the current-year periods also included one-time separation costs of approximately $0.3 million associated with the departure of an executive officer in the third quarter. As a result of a workforce reduction implemented in the fourth quarter of 2010, expenses in the fourth quarter will include additional one-time separation costs. As such, Rimage anticipates expenditures for selling, general and administrative activities in the fourth quarter to be comparable to third quarter 2010 expense levels.

 

 

 

Other income, net. The Company recognized net interest income on cash and marketable securities of $0.1 million and $0.4 million for the three and nine months ended September 30, 2010, compared to $0.3 million and $1.3 million for the same prior-year periods. The reduction in interest income in the current-year periods was the result of a decline in average effective yields relative to the same prior-year periods. This resulted from the Company’s change to a more conservative investment strategy as well as an environment of generally lower interest rates. Partially offsetting the impact of the

19



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

reduction in interest rates was a $5.1 million and $10.1 million increase in average cash equivalent and marketable securities balances for the three and nine months ended September 30, 2010 compared to the same periods in the prior year. Other income for the nine months ended September 30, 2009 includes the Company’s recognition in the second quarter 2009 of a gain on sale of marketable securities of $0.3 million as a result of the sale of approximately $33 million of municipal securities and reinvestment in U.S. treasury securities. Other income for the three and nine months ended September 30, 2010 also included net gains on foreign currency transactions of $38,000 and $6,000, respectively, compared to net gains of $5,000 and $47,000 for the same periods in the prior year.

 

 

 

Income taxes. The provision for income taxes represents federal, state and foreign income taxes on income. Income tax expense for the three and nine months ended September 30, 2010 amounted to $1.3 million and $3.0 million, respectively, or 36.8% and 37.2% of income before taxes in each respective period. Income tax expense for the three and nine months ended September 30, 2009 was $1.8 million and $3.7 million, or 36.3% and 37.4% of income before taxes in each respective period. The effective tax rate for the current-year periods was favorably affected by a shift in the mix of projected pre-tax earnings between the U.S. and the Company’s Japanese subsidiary, an increased benefit from the Section 199 deduction, impacted by an increase in the rate applied to excludable production activities income from 6% to 9% effective January 1, 2010 and a reduction in state income tax expense due primarily to a reduction in apportionment factors in certain states. Unfavorably impacting the effective tax rate for both current-year periods was the impact of a significantly reduced amount of projected tax-exempt interest income comprising a smaller percentage of pre-tax income and the expiration of the federal research credit effective January 1, 2010, resulting in no tax benefit in the current periods.

 

 

 

Net income / net income per share. Resulting net income attributable to Rimage for the three and nine months ended September 30, 2010 was $2.3 million and $5.1 million, respectively, or 10% and 8% of revenues for the respective periods. Comparable amounts for the three and nine months ended September 30, 2009 were $3.1 million and $6.3 million, respectively, or 14% and 10% of revenues, respectively. Related net income per diluted share amounts were $0.24 and $0.53 for the three and nine months ended September 30, 2010, respectively, compared to $0.33 and $0.66 per diluted share for the respective prior-year periods.

 

 

 

Liquidity and Capital Resources

 

 

 

The Company expects it will be able to maintain current operations and anticipated capital expenditure requirements for the foreseeable future through its internally generated funds. Prior to July 1, 2010, the Company had a credit agreement which allowed for advances under an unsecured revolving loan up to a maximum advance of $10 million. The credit agreement expired in accordance with its terms effective July 1, 2010, and is not expected to be renewed in the near term.

 

 

 

At September 30, 2010, the Company had working capital of $112 million, up $8.6 million from working capital reported at December 31, 2009. The increase was primarily the result of the impact of a non-cash change in the classification of $2.3 million of marketable securities from non-current as of December 31, 2009 to current as of September 30, 2010, net income adjusted for non-cash items of $8.2 million, a contribution of $0.6 million from the noncontrolling interest in the Company’s joint venture in China and proceeds from stock option exercises of $0.5 million, partially offset by the use of $3.8 million of cash to purchase property and equipment.

20



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

On October 17, 2007, the Company’s Board of Directors authorized the repurchase of up to 500,000 shares of its common stock. In February 2008, the Company’s Board of Directors increased the share repurchase authorization by an additional 500,000 shares, bringing total shares authorized for repurchase to 1,000,000. Shares may be purchased at prevailing market prices in the open market or in private transactions, subject to market conditions, share price, trading volume and other factors. The repurchase program may be discontinued at any time. The Company will finance the purchase of the shares, if any, using cash on hand. During the three and nine months ended September 30, 2010, the Company did not repurchase any shares of its common stock, and 422,917 shares remained available for repurchase under the authorizations as of September 30, 2010. Effective October 2010, the Company’s Board approved the continuation of common stock repurchases under the current authorization, and the Company repurchased less than $350,000 of its common stock during the fourth quarter prior to the filing of this Form 10-Q. The Company also intends on utilizing its cash primarily for its continued organic growth and potential future strategic initiatives or alliances.

 

 

 

Net cash provided by operating activities totaled $6.0 million for the nine months ended September 30, 2010, compared to $11.9 million in the same prior-year period. The $5.9 million decrease in cash generated from operating activities resulted from changes in operating assets and liabilities producing a $2.2 million net use of cash for the nine months ended September 30, 2010, compared to a $4.1 million net increase in cash for the same period in 2009, partially offset by a $0.4 million increase in net income adjusted for non-cash items in the current-year period. Primarily contributing to the change in operating assets and liabilities compared to the prior-year period were unfavorable changes of $3.0 million in inventories, $3.2 million in deferred income, $1.8 million in the aggregate amount of prepaid expenses and income taxes payable, and $0.7 million in the aggregate amount of trade accounts payable, accrued compensation and accrued expenses, partially offset by a $2.4 million smaller increase in receivables. The change in inventories resulted from a $1.5 million increase in the current year-to-date period, compared to a $1.5 million decline in the prior year, impacted by a change in the Company’s sales model effective April 1, 2010 under which it sells products to end-user customers through value-added resellers instead of through distributors in major markets, requiring increased inventory levels. The change in deferred income resulted from a $0.6 million decrease in the current year-to-date period, compared to a $2.6 million increase in the same prior-year period, resulting from a lower volume of maintenance contract renewals in 2010 compared to the prior year. The unfavorable change in prepaid expenses and income taxes payable was impacted primarily by the amount and timing of payments for estimated income taxes, value added taxes and prepaid maintenance contracts. The unfavorable change in the aggregate amount of trade accounts payable, accrued compensation and accrued expenses resulted primarily from increased payments in the current-year period for annual incentive bonuses to employees for calendar year 2009 performance and expenditures for property and equipment, partially offset by a higher level of inventory purchases and accrued development expenses remaining in accounts payable at the end of the period. The smaller increase in receivables in the current-year period was primarily impacted by a smaller increase in sales in the last two months of third quarter 2010 from the last two months in 2009 compared to the change in same prior-year periods.

 

 

 

Investing activities provided net cash of $17.2 million for the nine months ended September 30, 2010, compared to a net use of cash of $14.9 million for the same prior-year period. The fluctuations in investing activities were primarily the result of $21.0 million in maturities of marketable securities during the nine months ended September 30, 2010, compared to $14.7 million in purchases of marketable securities, net of related maturities, in the same prior-year period. Purchases of property and equipment during the nine months ended September 30, 2010 and 2009 amounted to $3.8 million and $0.2 million, respectively. Capital expenditures in the current-year period included $2.4 million of production tooling capitalized by the Company in late 2009 associated with a new product line launched during the first quarter of 2010. Remaining capital expenditures in the current-year period

21



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

consisted primarily of costs to support the Company’s information technology infrastructure related requirements.

 

 

 

Financing activities generated net cash of $1.1 million and $0.3 million for the nine months ended September 30, 2010 and 2009, respectively. The increase in the current period was primarily due to a $0.6 million contribution from the noncontrolling interest in the Company’s majority-owned joint venture established in China in the third quarter and increased proceeds from stock option exercises of approximately $0.3 million.

 

 

 

Critical Accounting Policies

 

 

 

Management utilizes its technical knowledge, cumulative business experience, judgment and other factors in the selection and application of the Company’s accounting policies. The accounting policies considered by management to be the most critical to the presentation of the consolidated financial statements because they require the most difficult, subjective and complex judgments include revenue recognition, allowance for doubtful accounts, inventory provisions, deferred tax asset valuation allowances, accruals for uncertain tax positions, stock-based compensation and impairment of long-lived assets. These accounting policies are discussed in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2009. Additionally, effective January 1, 2010, the Company adopted two new revenue recognition standards described in Note 10, “Recently Issued Accounting Standards,” which further augment the polices described in the Company’s Form 10-K. Management made no significant changes to the Company’s critical accounting policies during the nine months ended September 30, 2010.

 

 

 

In applying its critical accounting policies, management reassesses its estimates each reporting period based on available information. Changes in such estimates did not have a significant impact on the Company’s consolidated financial statements for the nine months ended September 30, 2010.

 

 

 

Cautionary Note Regarding Forward-Looking Statements

 

 

 

This report contains forward-looking statements that involve risks and uncertainties. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties. The Company’s actual results could differ significantly from those discussed in the forward-looking statements.

 

 

 

Factors that could cause or contribute to such differences include, but are not limited to, the following, as well as other factors not now identified: the economic health of the markets from which Rimage derives its sales and, in particular, the strength of the economies within North America and Europe where the Company has averaged 92% of total sales over the past three years; the Company’s ability to keep pace with changes in technology in the computer and storage media industries as well as technology changes in the Company’s targeted markets; increasing competition and the ability of the Company’s products to successfully compete with products of competitors and newly developed media storage products; the ability of the Company’s newly developed products to gain acceptance and compete against products in their markets; the significance of the Company’s international operations and the risks associated with international operations including currency fluctuations, local economic

22



 

 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (Continued)

 

 

 

health and management of these operations over long distances; the Company’s ability to protect its intellectual property and to defend claims of others relating to its intellectual property; the Company’s ability to effectively market its products and serve customers through its value-added resellers, distributors, strategic partners and its own sales force; the Company’s ability to maintain adequate inventory of products; the Company’s reliance on single source suppliers; the ability of the Company’s products to operate effectively with the computer products developed and to be developed by other manufacturers; the negative effect upon the Company’s business from manufacturing or design defects; the effect of U.S. and international regulation; fluctuations in the Company’s operating results; the Company’s dependence upon its key personnel; the volatility of the price of the Company’s common stock; provisions governing the Company relating to a change of control, compliance with corporate governance and securities disclosures rules and other risks, including those set forth in the Company’s reports filed with the Securities and Exchange Commission, including Item 1A of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2009. These forward-looking statements are made as of the date of this report and the Company assumes no obligation to update such forward-looking statements, or to update the reasons why actual results could differ materially from those anticipated in such forward-looking statements.

 

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

 

 

The Company is exposed to market risk from foreign exchange rate fluctuations of the European Euro, Japanese Yen and Chinese Yuan to the U.S. dollar as the financial position and operating results of the Company’s German subsidiary, Rimage Europe GmbH, its Japanese subsidiary, Rimage Japan Co., Ltd. and its majority-owned Chinese joint venture, Rimage Information Technology (Shanghai) Co., Ltd. are translated into U.S. dollars for consolidation. Resulting translation adjustments are recorded as a separate component of stockholders’ equity.

 

 

 

The Company enters into forward exchange contracts principally to hedge intercompany receivables denominated in Euros arising from sales to its subsidiary in Germany. Gains or losses on forward exchange contracts are calculated at each period end and are recognized in net income in the period in which they arose. The Company records the fair value of its open forward foreign exchange contracts in other current assets or other current liabilities depending on whether the net amount is a gain or a loss. The Company does not utilize financial instruments for trading or other speculative purposes.

 

 

 

Item 4. Controls and Procedures

 

 

 

(a) Evaluation of Disclosure Controls and Procedures

 

 

 

The Company’s Chief Executive Officer, Sherman L. Black, and the Company’s Chief Financial Officer, James R. Stewart, have evaluated the Company’s disclosure controls and procedures as of September 30, 2010. Based upon such evaluation, they have concluded that these disclosure controls and procedures are effective. The Company’s Chief Executive Officer and Chief Financial Officer used the definition of “disclosure controls and procedures” as set forth in Rule 13a-15(e) under the Exchange Act in making their conclusion as to the effectiveness of such controls and procedures.

 

 

 

(b) Changes in Internal Control Over Financial Reporting

23


There have been no changes in internal controls over financial reporting that occurred during the third quarter ended September 30, 2010 that have materially affected, or are reasonable likely to materially affect, the Company’s internal control over financial reporting.

 

 

 

 

PART II — OTHER INFORMATION

 

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

 

Not Applicable.

 

 

 

 

 

 

 

Item 1A.

Risk Factors

 

 

 

 

 

Not Applicable.

 

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

 

Not Applicable.

 

 

 

 

 

 

 

Item 3.

Defaults Upon Senior Securities

 

 

 

 

 

Not Applicable.

 

 

 

 

 

 

 

Item 4.

[Removed and Reserved]

 

 

 

 

 

Item 5.

Other Information

 

 

 

 

 

Not Applicable.

 

 

 

 

 

 

 

Item 6.

Exhibits

 

 

 

 

 

(a)     The following exhibits are included herein:

 

 

 

 

 

 

31.1

Certification of Chief Executive Officer pursuant to Rules 13a-14 and 15d-14 of the Exchange Act.

 

 

 

 

 

 

31.2

Certification of Chief Financial Officer pursuant to Rules 13a-14 and 15d-14 of the Exchange Act.

 

 

 

 

 

 

32

Certifications pursuant to 18 U.S.C. §1350.



24


SIGNATURES

In accordance with the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.

 

 

 

RIMAGE CORPORATION

 

Registrant


 

 

 

Date: November 8, 2010

By:

/s/ Sherman L. Black

 

 

Sherman L. Black

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

Date: November 8, 2010

By:

/s/ James R. Stewart

 

 

James R. Stewart

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 

(Principal Accounting Officer)





25